TechNavio today launched its report Global Neuromodulation Market 2011“2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers™ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said; Less invasive and non-invasive neuromodulation treatments are gaining greater acceptance among doctors and surgeons in the Healthcare industry. New lines of research in the R&D sector are enabling surgeons and healthcare specialists to do more selective stimulation, for instance, with respect to the innervation of the bladder at more peripheral sites, such as pudendal nerve stimulation, with the use of less invasive devices, such as Bion and other implantable devices.
According to the report, the growth of the Neuromodulation market in the US is expected to be due in part to a strong increase in demand as companies target both physicians and the general public with marketing and advertising campaigns. The Global Neuromodulation market will also benefit from the introduction and adoption of new, higher-priced devices with superior features in the US over the period 2011“2015.
Further, the report also discusses that expensive neuromodulation treatment costs hampers the growth of the Global Neuromodulation market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-neuromodulation-market-2011-2015
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report “ Global Neuromodulation Market 2011“2015
